Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01204931 · ClinicalTrials.gov registry record
Can We Predict Who Has Gastroesophageal Reflux Disease (GERD)?
A clinical trial, sponsored by Vanderbilt University.
- Completed
- Registry status
- 254
- Enrollment target
NCT01204931: Completed study, sponsored by Vanderbilt University.
NCT01204931 is a clinical trial that has completed, run by Vanderbilt University. The registered enrollment target is 254 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01204931 has completed, sponsored by Vanderbilt University.
- COMPLETED
- Registry status
- 254 participants
- Enrollment target
Study Summary
Gastroesophageal reflux disease (GERD) is currently defined as "a condition which develops when the reflux of stomach contents causes troublesome symptoms and/or complications". Doctors often diagnose and treat GERD based on symptoms of heartburn and regurgitation. In recent years, the prevalence of partial or non-response to Proton Pump Inhibitors (PPI) has increased resulting in diagnostic testing with esophagogastroduodenoscopy (EGD) or ambulatory pH monitoring. Most patients do not have endoscopic evidence for reflux. Thus, in this group pH monitoring has emerged as an important physiologic test to determine the degree of esophageal acid exposure and to assess the association between patients' persistent symptoms and acid reflux events. The aims of this study are to assess the sensitivity and specificity of symptom associated indices and determine the best parameter for predicting GERD from a list of conventional pH measurement findings.
Primary Outcome
Assess the sensitivity and specificity of symptom association indices (SI and SAP)regarding gastroesophageal reflux disease (GERD)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 254 participants |
| Start Date | 2010-11 |
| Est. Completion | 2015-06 |
What the finished NCT01204931 record still lists
NCT01204931 is an observational study that tracks outcomes without assigning an intervention. The registered 254 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01204931 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01204931 about?
NCT01204931 is a clinical study titled "Can We Predict Who Has Gastroesophageal Reflux Disease (GERD)?". Gastroesophageal reflux disease (GERD) is currently defined as "a condition which develops when the reflux of stomach contents causes troublesome symptoms and/or complications". Doctors often diagnose and treat GERD based on symptoms of heartburn and regurgitation. In recent years, the prevalence of...
What is the current status of trial NCT01204931?
This trial is currently completed. The enrollment target is 254 participants. The study started on 2010-11. Estimated completion is 2015-06.
Who is sponsoring clinical trial NCT01204931?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04390737 · 254 participants · Phase 1
Evaluate the Safety and Clinical Activity of HH2853
- NCT04677647 · 254 participants · NA
OurChild: A Health IT Solution to Reduce Minority Health Disparities
- NCT05503797 · 254 participants · Phase 2
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- NCT06167317 · 254 participants · Phase 1
Study of GS-0201 Alone and in Combination in Participants With Advanced Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia